New issue of Blood Advances out now featuring: FLT3-ITD measurable residual disease from the QuANTUM-First trial, Low bone mineral density and pain impact in adults with SCD, Antibiotic risk score for acute graft-versus-host disease and more. ashpublications.org/bloodadv…
We are looking for two talented and enthusiastic PhD students to work on a recently awarded ZonMW Open Competition project grant entitled “Phase separation-controlled gene transcription in leukemia”. Please apply at the UMCG vacancy site.
Honored to receive the Abstract Achievement Award at #ASH24 ! I’m grateful to everyone who stopped by for the insightful discussions and to all the collaborators who made this work possible. Thank you! @SchuringaLab@ASH_hematology
So happy to present our work at the #ASH24! I’m very honoured to be a recipient of the abstract achievement award this year. Many thanks to all the collaborators involved in this project @SchuringaLab@QuekLab@FrezzaLab@jeansarry
We are at the #ASH2024! Check out today poster #1393 about the role of lipid metabolism in metformin sensitivity in AML from @dominiqueasr and #1539 with the mechanisms of MLL5-driven leukemic transformation from @luisesimoes
Fantastic talk from @SchuringaJan on the latest data from the @SchuringaLab about the metabolic heterogeneity in AMLs and the role of the tumor microenvironment on metabolic abnormalities/adaptation in AML at #EHA2024!
I am very grateful to the @young_eha committee for this opportunity to share this great collaborative work from the @SchuringaLab, #RegoLab, and @QuekLab on metabolism in AML! Looking forward to the next talks at #EHA2024!
Exciting days at #EHAReCon2024! Got to see great science and meet some amazing people. I was also delighted with the opportunity to present our work on metformin and lipid metabolism in AML. Looking forward to next year! @EHA_Hematology@SchuringaLab
Congratulations @a_cunningham91 and @LieveOudejans and @SchuringaLab 🤩🤩👏🏻👏🏻 🌟 The 'non-essential' amino acid cysteine is required to prevent ferroptosis in acute myeloid leukemia ashpublications.org/bloodadv…
Delighted to present at #ASH2023 our story on CEBPA-regulated DeltaTP73 expression mimicking TP53mut AML! Very grateul for this amazing collaboration between the @SchuringaLab, @QuekLab and the RegoLab. Pre-print coming soon!
Great start at #ASH2023 with Dr. @IWeinhauser presentation on metabolic vulnerabilities in AML! Great collaboration of the @SchuringaLab, RegoLab-USP/BR and the @QuekLab!
Delighted to present our latest story regarding the TP53-mut like AMLs at #EHA2023! Amazing collaboration between the @SchuringaLab, RegoLab and @QuekLab! Thanks @EHA_Hematology for the opportunity to present our work!